ID   BR96
AC   CVCL_LG15
SY   BR96 (NL2); BR 96
DR   ATCC; HB-10036
DR   Wikidata; Q54798183
RX   Patent=US5491088;
RX   PubMed=1690595;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10036.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI:59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
RX   Patent=US5491088;
RA   Hellstrom I., Hellstrom K.E., Folger-Bruce K.R., Schreiber G.J.;
RT   "Monoclonal antibody BR 96 and chimeric monoclonal antibodies having
RT   the variable region of MAB BR96, which bind to a variant of ley
RT   antigen on human carcimona cells.";
RL   Patent number US5491088, 13-Feb-1996.
//
RX   PubMed=1690595;
RA   Hellstrom I., Garrigues H.J., Garrigues U., Hellstrom K.E.;
RT   "Highly tumor-reactive, internalizing, mouse monoclonal antibodies to
RT   Le(y)-related cell surface antigens.";
RL   Cancer Res. 50:2183-2190(1990).
//